Key points are not available for this paper at this time.
Our work indicates that a variety of deleterious CHEK2 alleles make an appreciable contribution to breast cancer susceptibility, and their identification could help in the clinical management of patients carrying a CHEK2 mutation.
Desrichard et al. (Thu,) studied this question.